| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 03/16/2006 | CA2578049A1 Delta 6-desaturase genes and uses thereof |
| 03/16/2006 | CA2575753A1 Muteins of fibroblast growth factor 21 |
| 03/16/2006 | CA2549218A1 Cell lines for use in increasing protein yield from a cell culture |
| 03/15/2006 | EP1634953A2 Platelet-activating factor acethylhydrolase |
| 03/15/2006 | EP1634947A1 Extract from cultured mammalian cell, process for preparation thereof and method of cell-free protein synthesis using the extract |
| 03/15/2006 | EP1634892A2 Composition and methods for the diagnosis of tumours |
| 03/15/2006 | EP1633866A1 New biological entities and the pharmaceutical or diagnostic use thereof |
| 03/15/2006 | EP1633865A1 New biological entities and the use thereof |
| 03/15/2006 | EP1633862A2 Method for production of c30-aldehyde carotenoids |
| 03/15/2006 | EP1633769A1 Novel transcription factor, bp1 |
| 03/15/2006 | EP1633381A2 Assays using amyloid precursor proteins with modified beta-secretase cleavage sites to monitor beta-secretase activity |
| 03/15/2006 | EP1633378A2 Pediocin-producing pediococci |
| 03/15/2006 | EP1572983A4 Culture chamber for biologicals |
| 03/15/2006 | EP1549757A4 Method of purifying lantibiotics |
| 03/15/2006 | EP1512004B1 Method for mapping and eliminating t-cell epitopes |
| 03/15/2006 | EP1364030B1 Supersecretable peptides, processes for their production, and parallel improvement of the secreted form of one or more other polypeptides |
| 03/15/2006 | EP1342730B1 Fusion protein having the enhanced in vivo activity of erythropoietin |
| 03/15/2006 | EP1294893B1 Modification of hepatitis b core antigen |
| 03/15/2006 | EP1246905B1 Histone deacetylase-8 proteins, nucleic acids, and methods of use |
| 03/15/2006 | EP1162997B1 Staphylococcus antigen and vaccine |
| 03/15/2006 | EP1121600B1 Method and substances for diagnosis and therapy of sepsis and sepsis-like systemic infections |
| 03/15/2006 | EP1045914B1 Testis-specific human svph1-8 proteinase |
| 03/15/2006 | EP1035863B1 An over-expressing homologous antigen vaccine and a method of making the same |
| 03/15/2006 | EP0942973B1 Mutants of the lag-3 proteins, products for the expression of these mutants and use |
| 03/15/2006 | EP0804592B1 Calcium free subtilisin mutants |
| 03/15/2006 | EP0784477B1 Immunotherapeutic stress protein-peptide complexes against cancer |
| 03/15/2006 | EP0733069B1 Purified primate ctla-8 antigens and related reagents |
| 03/15/2006 | EP0733064B1 Nucleic acids encoding a house dust mite allergen, (der p iii), and uses therefor |
| 03/15/2006 | EP0698105B1 Nucleotide sequences for the control of the expression of dna sequences in a cellular host |
| 03/15/2006 | CN1748143A Transgenic mice expressing human cd20 and/or cd16 |
| 03/15/2006 | CN1748027A Cold-induced expression vector |
| 03/15/2006 | CN1747712A Methods of producing lignin peroxidase and its use in skin and hair lightening |
| 03/15/2006 | CN1746313A Production of recombinant anthrax protective antigen and its special expression plasmid |
| 03/15/2006 | CN1746308A Eukaryon expression of coli heat-sensitive toxin B subunit |
| 03/15/2006 | CN1746303A Carrier and engineering bacteria for expressing extremehalophile purple membrane |
| 03/15/2006 | CN1746302A Production of Non-N glycosylated protein from yeast |
| 03/15/2006 | CN1746190A Modified peptides as therapeutic agents |
| 03/15/2006 | CN1746189A Modified peptides as therapeutic agents |
| 03/15/2006 | CN1746187A Atrial fibrillation peccant gene and use thereof |
| 03/15/2006 | CN1746186A Atrial fibrillation peccant gene and use thereof |
| 03/15/2006 | CN1245515C Gene of L-lactate dehydrogenase, recombined carrier containing said gene and host-cell thereof |
| 03/15/2006 | CN1245512C Vaccines containing recombinant pilin against i cneisseria gonorrhoeae (or i cneisseria meningitidis) |
| 03/15/2006 | CN1245509C Production of hirudin mutant HV2-Lys47 and special expression carrier and strain |
| 03/15/2006 | CN1245419C Polynucleotides and polypeptides BASB033 from neisseria meningitidis and their uses |
| 03/14/2006 | US7013219 Regulation of endogenous gene expression in cells using zinc finger proteins |
| 03/14/2006 | US7012135 Genetic engineering; monoclonal antibody grafted to tumor necrosis factor |
| 03/14/2006 | US7012133 Antibodies to C-C chemokine Receptor 3 Protein |
| 03/14/2006 | US7012132 Modified factor VIII |
| 03/14/2006 | US7011974 Using hybridomas cells; gene expression; monoclonal antibodies |
| 03/14/2006 | US7011969 Preparing surface tension protein via genetcally engineered bacillus culture for use in detergents, emulsifiers, wetting agents, dispersants, solubilizing agents, antistatic agents, cosmetics, foods and medical preparations |
| 03/14/2006 | US7011958 Generating stable nucleic acids in in vitro translation/ transcription systems; prepare cell free transcription/ translation system, mix with reaction mixture and random nucleotide sequences, monitor transcription/translation |
| 03/14/2006 | US7011836 Neisseria having mutations in genes which causes the bacterium to lack endotoxic lipopolysaccharides, used for inoculation; genetic engineering; knockouts |
| 03/14/2006 | CA2298106C A recombinant expression vector of human parathyroid hormone |
| 03/14/2006 | CA2192942C Synthetic leader peptide sequences |
| 03/14/2006 | CA2154854C Immortalized lymphocytes for production of viral-free proteins |
| 03/14/2006 | CA1341501C Vectors for the expression and segregation of hirudine by transformed yeasts |
| 03/09/2006 | WO2006026447A2 PRODUCTION OF TNFR-Ig FUSION PROTEIN |
| 03/09/2006 | WO2006026445A1 Production of polypeptides |
| 03/09/2006 | WO2006026408A2 Production of anti-amyloid beta antibodies |
| 03/09/2006 | WO2006025580A1 Anti-histone h1 monoclonal antibody and hybridoma capable of producing the same |
| 03/09/2006 | WO2006025345A1 Antihuman baff antibody |
| 03/09/2006 | WO2006025295A1 Yeast strain releasing mannan protein and method of producing mannan protein |
| 03/09/2006 | WO2005090566A3 Ligational encoding using building block oligonucleotides |
| 03/09/2006 | WO2005082927A3 Antihypertensive peptides |
| 03/09/2006 | WO2005079183A3 Method for production of c30-aldehyde carotenoids |
| 03/09/2006 | WO2005077976A3 Coiled-coil domains from c4b-binding protein |
| 03/09/2006 | WO2005063820A3 Il-7 fusion proteins |
| 03/09/2006 | US20060053514 encoded by the cellobiohydrolase II encoding part of the nucleotide sequence present in a microorganism selected from the species Chaetomiaceae, Myceliophthora, Acremonium, Melanocarpus Thielavia microspora, Aspergillus sp., Thielavia australiensis |
| 03/09/2006 | US20060053502 Systems and methods for protein production |
| 03/09/2006 | US20060053500 Modification of sugar metabolic processes in transgenic cells, tissues and animals |
| 03/09/2006 | US20060053498 Full-length human cdnas encoding potentially secreted proteins |
| 03/09/2006 | US20060053496 Caterpiller gene family |
| 03/09/2006 | US20060052593 diagnostics, and vaccines for prophylactic and therapeutic treatment of cancers, particularly ovarian and colon cancers, autoimmune diseases, and related conditions |
| 03/09/2006 | US20060052591 Methods and materials relating to carcinoembryonic antigen-like (cea-like) polypeptides and polynucleotides |
| 03/09/2006 | US20060052585 Method for the generation of genetically modified vertebrate precursor lymphocytes and use thereof for the production of heterologous binding proteins |
| 03/09/2006 | US20060052584 Human-derived bradeion proteins, DNA coding for the proteins, and uses thereof |
| 03/09/2006 | US20060052335 Chondroitin synthetase and dna encoding the enzyme |
| 03/09/2006 | US20060052329 Regulation of human P2Y1-like G protein-coupled receptor |
| 03/09/2006 | US20060052321 Nucleic acid and corresponding protein entitled 98P4B6 useful in treatment and detection of cancer |
| 03/09/2006 | US20060052300 Treating a condition treatable by aprotinin by administering a polypeptide having a KD1 domain with a primary structure that is at least 86% identical to the primary structure of the wild-type KD1 domain of human tissue factor pathway inhibitor-2, but does not include a KD2 or KD3 domain; cardiovascular |
| 03/09/2006 | US20060052294 Muteins of the c5a anaphylatoxin, nucleic acid molecules encoding such muteins, and pharmaceutical uses of muteins of the c5a anaphylatoxin |
| 03/09/2006 | US20060052291 Chemically-modified progenipoietin conjugates |
| 03/09/2006 | US20060052285 Induction of mitochondrial membrane permeabilization via the physical and functional interaction of the HIV-1 Vpr protein with the mitochondrial inner membrane protein ANT (also called adenine nucleotide translocase or ADP/ATP carrier) |
| 03/09/2006 | US20060052282 Diagnostic and therapeutic means for pathologies associated with alpha 2 subunit of the na, k pump |
| 03/09/2006 | US20060051877 Fibronectin biopolymer marker indicative of insulin resistance |
| 03/09/2006 | US20060051869 Transport proteins and their uses |
| 03/09/2006 | US20060051861 Cell lines for use in increasing protein yield from a cell culture |
| 03/09/2006 | US20060051853 Human MEKK proteins, corresponding nucleic acid molecules and uses therefor |
| 03/09/2006 | US20060051852 Apyrase polypeptides and nucleic acids encoding same |
| 03/09/2006 | US20060051851 Novel selenocysteine-containing protein |
| 03/09/2006 | US20060051850 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 03/09/2006 | US20060051844 Human EPO mimetic hinge core mimetibodies, compositions, methods and uses |
| 03/09/2006 | US20060051843 Fluorescent protein for use as resolution tools in genetic analysis |
| 03/09/2006 | US20060051842 Nucleic acid encoding alpha chain of human IL-11 receptor |
| 03/09/2006 | US20060051841 Identification, cloning, expression, and purification of three novel human calcium-independent phospholipase A2 family members possessing triacylglycerol lipase and acylglycerol transacylase activities |
| 03/09/2006 | US20060051840 Hybrid expression of neisserial proteins |
| 03/09/2006 | US20060051839 DNA expression vectors and methods of use |
| 03/09/2006 | US20060051838 Genetic computing using combinatorial transcription control |
| 03/09/2006 | US20060051837 Polynucleotides and polypeptides coded by said polynucleotides involved in the synthesis of diketopiperazine derivatives |
| 03/09/2006 | US20060051836 Molecules for disease detection and treatment |